Loading clinical trials...
Loading clinical trials...
This study will determine the effectiveness of MK0777 GEM versus Lorazepam in the treatment of patients with generalized anxiety disorder. This is an early phase trial and some specific protocol info...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Merck Sharp & Dohme LLC
NCT05569018 · Anxiety Disorders, Depressive Disorders
NCT06768749 · Sleep Problems, Depressive Disorder and Anxiety Disorders
NCT06066983 · Autism Spectrum Disorder, Anxiety Disorders
NCT06968026 · Recurrent Pregnancy Loss, Anxiety Disorders
NCT07477990 · General Anxiety Disorder
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions